Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline plus captopril for stage 1 primary hypertension
IRCT20111206008307N31Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in essential hypertension comparing Pentoxifylline + captopril with Captopril + placebo (2 arms). Primary endpoint: Blood pressure change from baseline to 2 months. Started Apr 2019; status: completed.
02
Drugs
pentoxifyllinecaptopril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on IRCT20111206008307N31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111206008307N31.